Therapeutics: Tetratricopeptide repeat domain 39B (TTC39B)

Cardiovascular disease

INDICATION: Atherosclerosis; non-alcoholic steatohepatitis (NASH)

Mouse studies suggest inhibiting TTC39B

Read the full 108 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE